Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial.
Saved in:
| Title: | Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial. |
|---|---|
| Authors: | Winhusen TJ; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio.; University of Cincinnati/UC Health Addiction Center, Cincinnati, Ohio., Lofwall MR; Departments of Behavioral Science and Psychiatry, Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington., Kropp F; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio.; University of Cincinnati/UC Health Addiction Center, Cincinnati, Ohio., Lewis D; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio.; University of Cincinnati/UC Health Addiction Center, Cincinnati, Ohio., Smid MC; Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City., Young JL; Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee., Hodgkins C; Gateway Community Services, Jacksonville, Florida., Krans EE; Department of Obstetrics, Gynecology, and Reproductive Sciences, and Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Hansen Z; Department of Family Medicine, Division of Addiction Science, Marshall University, Huntington, West Virginia., Wachman EM; Department of Pediatrics, Boston Medical Center, Boston, Massachusetts., Schiff DM; Divisions of General Academic Pediatrics and Newborn Medicine, Mass General for Children, Boston, Massachusetts., Guille C; Department of Psychiatry and Behavioral Science, Medical University of South Carolina, Charleston., Rudolf V; Addiction Recovery Services, Swedish Medical Center, Seattle, Washington., Chowdhury T; CODA, Inc, Portland, Oregon., Leeman L; Department of Family and Community Medicine, University of New Mexico School of Medicine, Albuquerque., Lewis M; The Emmes Company, LLC, Rockville, Maryland., Matthews AG; The Emmes Company, LLC, Rockville, Maryland., Cochran G; Department of Internal Medicine, University of Utah, Salt Lake City., King J; The Emmes Company, LLC, Rockville, Maryland., Wilder C; Perinatal Addiction Program, University of Cincinnati Health, Cincinnati, Ohio.; Now with Hazelden Betty Ford Foundation, Center City, Minnesota., Rosa C; Center for the Clinical Trials Network, National Institute on Drug Abuse, Bethesda, Maryland (now retired). |
| Source: | JAMA internal medicine [JAMA Intern Med] 2026 May 01; Vol. 186 (5), pp. 533-543. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Equivalence Trial; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6114 |
|---|---|
| DOI: | 10.1001/jamainternmed.2026.0057 |
